GSA is a professional membership organization committed to promoting the best available interdisciplinary aging research to advance innovations in practice and policy. This is especially key to ...

Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

Robert F. Kennedy Jr.’s quest to reshape food policy in America took him to an event here with the state’s Republican ...

From hormonal factors to psychological factors, know the causes that can enhance challenges in managing obesity.

Novo Nordisk has licensed an oral obesity drug that works via an uncommon mechanism and may help patients maintain their ...

There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner.

New study finds that obesity reduces a specific brain chemical, lowering the desire to consume high-calorie foods. Boosting ...

Childhood obesity is a formidable public health challenge in the US, posing a risk of various downstream health issues for ...

Drug development is coming back in vogue and this fund’s ‘full life cycle’ approach means it’s ready to capture the gains ...

They're on our highways and our state roads. We see them at rest stops and service plazas. They move our economy. Literally.